Citius Share Price
NASDAQ: CTOR | Micro Cap | Healthcare$0.56
-$0.01 (-2.18%) Last updated on 18 Nov, 2026 | 20:52 ISTCitius Stock Performance
Citius Share Price Chart
$0.00$0.00
L
H
Citius Quarterly Profit & Loss
All figures in USD
Citius Annual Profit & Loss
All figures in USD
Citius Balance Sheet
All figures in USD Million
Citius Cash Flow
Annually
All figures in USD Million
About Citius
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Citius Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.61 | $0.57 | +13.94% |
Oct 2026 | $1.07 | $0.50 | -50.78% |
Sep 2026 | $0.74 | $1.02 | +34.21% |
Aug 2026 | $0.68 | $0.76 | +37.18% |
Jul 2026 | $0.71 | $0.55 | -18.77% |
Jun 2026 | $0.79 | $0.68 | -15.80% |
May 2026 | $0.89 | $0.81 | -8.99% |
Apr 2026 | $0.61 | $0.89 | +43.78% |
Mar 2026 | $1.08 | $0.62 | -42.95% |
Feb 2026 | $1.04 | $1.08 | +0.46% |
Jan 2026 | $1.01 | $1.08 | +10.32% |
Dec 2025 | $1.48 | $0.98 | -27.48% |